Innoviva Stock Just This: Why a Fund Bought $2.5M More
A boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
This intro contrasts SP 500 with target date funds, highlighting flexibility, fees, and potential growth paths relevant to retirement planning.
27,405 articlesA boutique fund recently boosted its Innoviva stake by $2.5 million, raising questions about the stock's modest 10% g...
A Massachusetts man fell for a phony online romance that morphed into a fake crypto investment. He ended up losing hu...
A focused look at contrarian investing: why a fund would build a million-commerce stake in a high-growth SaaS vendor ...
In 2025, Interactive Brokers stayed focused on the engine that powers long-term success: scale, discipline, and momen...
Insider buying can reveal confidence that outsiders may miss. This guide breaks down how to read the signals, separat...
SailPoint faced a sharp pullback after its latest results, sparking questions about growth and profitability. This ar...
A major fund sold a sizable stake in Darling Ingredients, but the stock defied expectations and surged. This article ...
A week after Walmart’s investor day, the stock surged as analysts highlighted margin discipline and cash returns. Thi...
A sudden move lower in AeroVironment stock has traders and long-term holders asking what happened. This guide breaks ...
Warren Buffett famously bailed on airlines in 2020. Now Berkshire Hathaway backs Delta with a multi-billion stake, si...
A sharp price drop followed by a sizable insider sale can mean many things. This guide walks through what to watch in...
A pension election could dramatically reshape survivor finances. A high-wealth household faces a stark tradeoff betwe...